EATG » Hepatitis

Hepatitis

Appeal lodged against decision to uphold Gilead’s patent on hepatitis C drug

Paris, 5 December 2018 – Six organisations, including Médecins Sans Frontières (MSF), have just appealed the European Patent Office’s September decision to uphold US pharmaceutical corporation Gilead Science’s patent on the…

The silent epidemic killing more people than HIV, malaria or TB

Viral hepatitis is on the rise. Tackling hepatitis B in Africa is key to fighting back. An article, published in Nature, examines global hepatitis B burden, death toll.  

Reporting from the 2nd Hep-C Community Summit (Lisbon, 18 September 2018)

The Hep-C Community Summit, organised by Correlation European Harm Reduction Network, has brought together people from the affected communities, advocates, researchers, healthcare providers, harm reduction practitioners, and policymakers to discuss…

Europe’s hepatitis challenge

A hidden epidemic is coming to light in Europe but under-reporting and late diagnosis continue to hamper progress in preventing hepatitis B and C infections. Vijay Shankar Balakrishnan reports. Most…

Hepatitis news

Reducing unnecessary medication for hepatitis B patients ********************** Perinatal HCV leads to earlier cirrhosis than other pediatric risk groups ********************** Prognostic marker pursued for relapse of occult hepatitis C genotype…

Vir Biotechnology and Alnylam Pharmaceuticals initiate Phase 1/2 study of VIR-2218

-- Novel investigational RNAi therapeutic for the treatment of chronic hepatitis B virus (HBV) infection -- Subject dosing commenced SAN FRANCISCO, Calif. and CAMBRIDGE, Mass. – November 26, 2018 -…

Countries of eastern Europe and central Asia improve access to HIV, TB and viral hepatitis diagnostic technologies and medicines

In 2017, 130 000 people acquired HIV in countries of eastern Europe and central Asia. Since 2010, the number of new infections has increased by 29%, making it the fastest-growing…

Australian experience shows high DAA uptake and rapid fall in rates of HCV viraemia among people who inject drugs

Providing hepatitis C virus (HCV) therapy with direct-acting antivirals (DAAs) to people who inject drugs can achieve rapid reductions in community prevalence of viraemia, according to Australian research published in…

Eliminating Hepatitis: A unique opportunity that shouldn’t be missed

EU policymakers owe it to Europe’s citizens to make hepatitis a thing of the past, argues Tatjana Reic. Hepatitis C (HCV) is an urgent public health problem for the European…

Eastern Europe and Central Asia adopt statement on fighting infectious diseases

MINSK, 22 November (BelTA) – The international statement on expanding access to affordable and quality assured medicines and diagnostics will help coordinate efforts of Eastern Europe and Central Asia (EECA)…